School of Medicine

Index of publications

• Articles
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
• Books
  • 1998
• Conference proceedings
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 1998
  • 1997

Publications

• Articles
  • 2013
    • Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.
      Welton JL, Morgan MP, Martí S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M, J Bone Miner Res, Volume 28, 3 (March 2013) pp.464-471
    • Suppression of pro-inflammatory T-cell responses by human mesothelial cells.
      Lin CY, Kift-Morgan A, Moser B, Topley N, Eberl M, Nephrol Dial Transplant (January 2013)
  • 2012
    • γδ T-cell conference 2012: close encounters for the fifth time.
      Silva-Santos B, Schamel WW, Fisch P, Eberl M, Eur J Immunol, Volume 42, 12 (December 2012) pp.3101-3105
    • Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?
      Riganti C, Massaia M, Davey MS, Eberl M, Eur J Immunol, Volume 42, 7 (July 2012) pp.1668-1676
    • HmgR, a key enzyme in the mevalonate pathway for isoprenoid biosynthesis, is essential for growth of Listeria monocytogenes EGDe.
      Heuston S, Begley M, Davey MS, Eberl M, Casey PG, Hill C, Gahan CG, Microbiology, Volume 158, Pt 7 (July 2012) pp.1684-1693
    • IL-21 enhances the potential of human γδ T cells to provide B-cell help.
      Bansal RR, Mackay CR, Moser B, Eberl M, Eur J Immunol, Volume 42, 1 (January 2012) pp.110-119
  • 2011
    • Failure to detect production of IL-10 by activated human neutrophils.
      Davey MS, Tamassia N, Rossato M, Bazzoni F, Calzetti F, Bruderek K, Sironi M, Zimmer L, Bottazzi B, Mantovani A, Brandau S, Moser B, Eberl M, Cassatella MA, Nat Immunol, Volume 12, 11 (November 2011) pp.1017-1018
    • A promising target for treatment of multidrug-resistant bacterial infections.
      Davey MS, Tyrrell JM, Howe RA, Walsh TR, Moser B, Toleman MA, Eberl M, Antimicrob Agents Chemother, Volume 55, 7 (July 2011) pp.3635-3636
    • γδ T-APCs: a novel tool for immunotherapy?
      Moser B, Eberl M, Cell Mol Life Sci, Volume 68, 14 (July 2011) pp.2443-2452
    • Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.
      Davey MS, Lin CY, Roberts GW, Heuston S, Brown AC, Chess JA, Toleman MA, Gahan CG, Hill C, Parish T, Williams JD, Davies SJ, Johnson DW, Topley N, Moser B, Eberl M, Plos Pathog, Volume 7, 5 (May 2011) p. e1002040
    • Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection.
      Clark SR, Guy CJ, Scurr MJ, Taylor PR, Kift-Morgan AP, Hammond VJ, Thomas CP, Coles B, Roberts GW, Eberl M, Jones SA, Topley N, Kotecha S, O'Donnell VB, Blood, Volume 117, 6 (February 2011) pp.2033-2043
    • Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
      Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RW, Breast Cancer Res, Volume 13, 5 (2011) p. R88
  • 2010
    • In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
      Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, La Mendola C, Guggino G, D'Asaro M, Orlando V, Scarpa F, Roberts A, Caccamo N, Stassi G, Dieli F, Hayday AC, Clin Exp Immunol, Volume 161, 2 (August 2010) pp.290-297
    • Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells.
      Meuter S, Eberl M, Moser B, Proc Natl Acad Sci U S A, Volume 107, 19 (May 2010) pp.8730-8735
    • The non-mevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally-regulated by Dxs
      Brown AC, Eberl M, Crick DC, Jomaa H, Parish T, J Bacteriol, Volume 192, 9 (May 2010) pp.2424-2433
  • 2009
    • Monocytes and gammadelta T cells: close encounters in microbial infection.
      Eberl M, Moser B, Trends Immunol, Volume 30, 12 (December 2009) pp.562-568
    • Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
      Brandes M, Willimann K, Bioley G, Lévy N, Eberl M, Luo M, Tampé R, Lévy F, Romero P, Moser B, Proc Natl Acad Sci U S A, Volume 106, 7 (February 2009) pp.2307-2312
    • A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections.
      Eberl M, Roberts GW, Meuter S, Williams JD, Topley N, Moser B, Plos Pathog, Volume 5, 2 (February 2009) p. e1000308
  • 2007
    • Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
      Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D'Asaro M, Gebbia N, Salerno A, Eberl M, Hayday AC, Cancer Res, Volume 67, 15 (August 2007) pp.7450-7457
    • Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
      Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M, Immunology, Volume 121, 1 (May 2007) pp.29-39
    • Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.
      Vermijlen D, Ellis P, Langford C, Klein A, Engel R, Willimann K, Jomaa H, Hayday AC, Eberl M, J Immunol, Volume 178, 7 (April 2007) pp.4304-4314
    • gammadelta T cells: novel initiators of adaptive immunity.
      Moser B, Eberl M, Immunol Rev, Volume 215 (February 2007) pp.89-102
  • 2006
    • Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells.
      Caccamo N, Dieli F, Wesch D, Jomaa H, Eberl M, J Leukoc Biol, Volume 79, 4 (April 2006) pp.663-666
  • 2005
    • Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1).
      Eberl M, Engel R, Aberle S, Fisch P, Jomaa H, Pircher H, J Leukoc Biol, Volume 77, 1 (January 2005) pp.67-70
    • Modern aspects of multiple sclerosis immunopathogenesis
      Nizjegorodova DB, Eberl M, Zafranskaja MM, Immunopathology Allergology Infectology, Volume 2 (2005) pp.44-55
  • 2004
    • Mycoplasma penetrans is capable of activating V gamma 9/V delta 2 T cells while other human pathogenic mycoplasmas fail to do so.
      Eberl M, Hintz M, Jamba Z, Beck E, Jomaa H, Christiansen G, Infect Immun, Volume 72, 8 (August 2004) pp.4881-4883
    • Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.
      Eberl M, Jomaa H, Hayday AC, Immunology, Volume 112, 3 (July 2004) pp.364-368
    • The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes.
      Begley M, Gahan CG, Kollas AK, Hintz M, Hill C, Jomaa H, Eberl M, Febs Lett, Volume 561, 1-3 (March 2004) pp.99-104
  • 2003
    • A genetic basis for human gammadelta T-cell reactivity towards microbial pathogens.
      Eberl M, Jomaa H, Trends Immunol, Volume 24, 8 (August 2003) pp.407-409
    • Microbial isoprenoid biosynthesis and human gammadelta T cell activation.
      Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H, Febs Lett, Volume 544, 1-3 (June 2003) pp.4-10
    • Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
      Reichenberg A, Hintz M, Kletschek Y, Kuhl T, Haug C, Engel R, Moll J, Ostrovsky DN, Jomaa H, Eberl M, Bioorg Med Chem Lett, Volume 13, 7 (April 2003) pp.1257-1260
    • Properties of 2-C-methyl-D-erythritol 2,4-cyclopyrophosphate, an intermediate in nonmevalonate isoprenoid biosynthesis
      Ostrovsky DN, Dyomina GR, Deryabina YI, Goncharenko AV, Eberl M, Shumaev KB, Shashkov AS, Applied Biochemistry And Microbiology, Volume 39, 5 (2003) pp.497-502
  • 2002
    • Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis.
      Kollas AK, Duin EC, Eberl M, Altincicek B, Hintz M, Reichenberg A, Henschker D, Henne A, Steinbrecher I, Ostrovsky DN, Hedderich R, Beck E, Jomaa H, Wiesner J, Febs Lett, Volume 532, 3 (December 2002) pp.432-436
    • A novel and sensitive method to monitor helminth infections by faecal sampling.
      Eberl M, al-Sherbiny M, Hagan P, Ljubojevic S, Thomas AW, Wilson RA, Acta Trop, Volume 83, 2 (August 2002) pp.183-187
    • Differentiation of human gamma-delta T cells towards distinct memory phenotypes.
      Eberl M, Engel R, Beck E, Jomaa H, Cell Immunol, Volume 218, 1-2 (July 2002) pp.1-6
    • Don't count your interleukins before they've hatched.
      Eberl M, Trends Immunol, Volume 23, 7 (July 2002) pp.341-342
    • Accumulation of a potent gammadelta T-cell stimulator after deletion of the lytB gene in Escherichia coli.
      Eberl M, Altincicek B, Kollas AK, Sanderbrand S, Bahr U, Reichenberg A, Beck E, Foster D, Wiesner J, Hintz M, Jomaa H, Immunology, Volume 106, 2 (June 2002) pp.200-211
  • 2001
    • Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli.
      Hintz M, Reichenberg A, Altincicek B, Bahr U, Gschwind RM, Kollas AK, Beck E, Wiesner J, Eberl M, Jomaa H, Febs Lett, Volume 509, 2 (December 2001) pp.317-322
    • Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees.
      Eberl M, Langermans JA, Frost PA, Vervenne RA, van Dam GJ, Deelder AM, Thomas AW, Coulson PS, Wilson RA, Infect Immun, Volume 69, 9 (September 2001) pp.5352-5362
    • LytB, a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli.
      Altincicek B, Kollas A, Eberl M, Wiesner J, Sanderbrand S, Hintz M, Beck E, Jomaa H, Febs Lett, Volume 499, 1-2 (June 2001) pp.37-40
    • Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive?
      Eberl M, Langermans JA, Vervenne RA, Nyame AK, Cummings RD, Thomas AW, Coulson PS, Wilson RA, J Infect Dis, Volume 183, 8 (April 2001) pp.1238-1247
    • Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis.
      Altincicek B, Moll J, Campos N, Foerster G, Beck E, Hoeffler JF, Grosdemange-Billiard C, Rodríguez-Concepción M, Rohmer M, Boronat A, Eberl M, Jomaa H, J Immunol, Volume 166, 6 (March 2001) pp.3655-3658
    • A calreticulin-like molecule from the human hookworm Necator americanus interacts with C1q and the cytoplasmic signalling domains of some integrins.
      Kasper G, Brown A, Eberl M, Vallar L, Kieffer N, Berry C, Girdwood K, Eggleton P, Quinnell R, Pritchard DI, Parasite Immunol, Volume 23, 3 (March 2001) pp.141-152
  • 2000
    • IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen.
      Eberl M, Beck E, Coulson PS, Okamura H, Wilson RA, Mountford AP, Vaccine, Volume 18, 19 (April 2000) pp.2002-2008
  • 1999
    • Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
      Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Türbachova I, Eberl M, Zeidler J, Lichtenthaler HK, Soldati D, Beck E, Science, Volume 285, 5433 (September 1999) pp.1573-1576
    • Isolation of T-cell antigens by using a recombinant protein library and its application to the identification of novel vaccine candidates against schistosomiasis.
      Eberl M, Mountford AP, Jankovic D, Beck E, Infect Immun, Volume 67, 7 (July 1999) pp.3383-3389
• Books
  • 1998
    • BSE, Creutzfeldt-Jakob & Co. – or: Is Madness transmissible?
      Appel N et al, Edition Kletsmeier (1998)
• Conference proceedings
  • 2013
    • Human gamma delta T cells in severe bacterial sepsis
      Morgan M, Szakmany T, Davey M, Hall JE, Eberl M, British Journal Of Anaesthesia, Volume 110, 5 (May 2013) pp.876-877
  • 2012
    • Co-ordinated crosstalk of human gamma delta T cells, neutrophils and monocytes in response to bacterial infections
      Davey MS, Morgan MPG, Hall JE, Moser B, Eberl M, Immunology, Volume 137 (September 2012) pp.104-105
    • Co-ordinated crosstalk of human gamma delta T cells, neutrophils and monocytes in response to bacterial infections
      Davey MS, Moser B, Eberl M, , Budapest, Hungary (March 2012) Eur J Clin Invest, Volume 42, s1 (2012) pp.15-15
  • 2011
    • Co-ordinated crosstalk of human gamma delta T cells, neutrophils and monocytes in response to bacterial infections
      Davey MS, Moser B, Eberl M, Immunology, Volume 135 (December 2011) pp.85-85
  • 2010
    • The HMB-PP producing capacity of the causative pathogen and local gamma delta T cell numbers predict clinical outcome from bacterial peritonitis
      Lin C, Roberts GW, Davey MS, Chess JA, Fielding CA, Williams JD, Davies SJ, Johnson DW, Moser B, Topley N, Eberl M, Immunology, Volume 131 (December 2010) pp.81-82
    • Monitoring the immunological effects of bisphosphonates in different treatment scenarios
      Binda E, Perez SM, Pandha H, Eberl M, Hayday A, Immunology, Volume 131 (December 2010) pp.117-117
    • Human gammadelta T cell responses in breast cancer patients during zoledronate therapy
      Perez SM, Binda E, Hayday AC, Barrett-Lee PJ, Eberl M, Immunology, Volume 131 (December 2010) pp.115-115
    • IL-21 induces the expression of markers associated with follicular B cell help by human gammadelta T cells
      Bansal RR, Mackay CR, Moser B, Eberl M, , Liverpool, England (December 2010) Immunology, Volume 131, Suppl. 1 (December 2010) pp.38-38
    • Innate crosstalk of gamma delta T cells, neutrophils and monocytes in response to HMB-PP producing bacteria
      Davey MS, Heuston S, Brown AC, Walsh TR, Toleman MA, Gahan CGM, Hill C, Parish T, Moser B, Eberl M, Immunology, Volume 131 (December 2010) pp.63-63
  • 2009
    • Human gammadelta T cell responses in acute bacterial infection
      Davey MS, Roberts G, Ciesielczuk H, Shorten R, Williams JD, Topley N, Moser B, Eberl M, , Berlin, Germany (September 2009) European Journal Of Immunology, Volume 39, S1 (September 2009)
    • IL-21 induces the expression of markers associated with follicular B cell help by human gammadelta T cells
      Bansal RR, Scott-Coombes D, Douglas-Jones A, Mackay CR, Moser B, Eberl M, , Berlin, Germany (September 2009) European Journal Of Immunology, Volume 39, S1 (September 2009)
    • Surface regulators of human gammadelta T cells
      Roberts AR, Vermijlen D, Jomaa H, Eberl M, Hayday AC, , Berlin, Germany (September 2009) European Journal Of Immunology, Volume 39, S1 (September 2009)
    • Microbial sensing by human gammadelta T cells drives the acute inflammation and bridges innate and adaptive immunity
      Eberl M, Roberts G, Davey MS, Meuter S, Williams JD, Topley N, Moser B, , Berlin, Germany (September 2009) European Journal Of Immunology, Volume 39, S1 (September 2009)
  • 2008
    • IL-21 induces the B cell attracting chemokine CXCL13 in human gd T cells
      Bansal RR, Meuter S, Moser B, Eberl M, Immunology, Volume 125 (December 2008) pp.101-101
    • Rapid differentiation of monocytes into inflammatory DCs through crosstalk with activated human T cells
      Eberl M, Roberts GW, Meuter S, Williams JD, Topley N, Moser B, Immunology, Volume 125 (December 2008) pp.6-6
    • IGSF4 as a candidate regulator of immune interactions involving gamma delta T cells
      Roberts AR, Vermijlen D, Jomaa H, Eberl M, Hayday AC, Immunology, Volume 125 (December 2008) pp.102-102
  • 2007
    • IGSF4 expression by unconventional T cells: a role in T-T interaction?
      Roberts A, Vermijlen D, Ellis P, Langford C, Eberl M, Hayday A, Immunology, Volume 120 (March 2007) pp.66-66
    • The functional plasticity of human gammadelta T cells: implications for cancer therapy and beyond
      Eberl M, Vermijlen D, Dieli F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Moser B, Jomaa H, Hayday AC, , Heidelberg, Germany (September 2007) (2007)
  • 2005
    • Gene expression analysis of human gamma delta T cells
      Vermijlen D, Eberl M, Ellis P, Langford C, Hayday A, , Harrogate, U.K. (December 2005) Immunology, Volume 116, S1 (December 2005) pp.14-14
    • Gene expression profiling of phenotypically and functionally distinct human Vg9/Vd2 T cell populations
      Eberl M, Vermijlen D, Klein A, Engel R, Ellis P, Langford C, Jomaa H, Hayday AC, , Kiel, Germany (September 2005) Immunobiology, Volume 210, 6-8 (September 2005)
    • Interferon-beta therapy reduces autoreactive CD4+ and CD8+ memory T cells in multiple sclerosis
      Zafranskaya M, Engel R, Weishaupt A, Oschmann P, Jomaa H, Eberl M, , Kiel, Germany (September 2005) Immunobiology, Volume 210, 6-8 (September 2005)
  • 2004
    • Bacterial immunogenicity and human Vg9/Vd2 T cell reactivity
      Eberl M, Hill C, Christiansen G, Jomaa H, , Maastricht, The Netherlands (October 2004) Immunobiology, Volume 209, 4-6 (2004)
  • 2003
    • A genetic basis for human gammadelta T cell reactivity towards microbial pathogens
      Eberl M, Jomaa H, , Harrogate, U.K. (December 2003) Immunology, Volume 110, S1 (December 2003)
    • The natural Vg9/Vd2 T cell activator HMB-PP triggers sustained signalling through the T cell receptor
      Lafont V, Reichenberg A, Jomaa H, Eberl M, , Harrogate, U.K. (December 2003) Immunology, Volume 110, S1 (December 2003)
    • The natural Vg9/Vd2 T cell activator HMB-PP triggers sustained signalling through the T cell receptor
      Lafont V, Reichenberg A, Jomaa H, Eberl M, , Berlin, Germany (September 2003) Immunobiology, Volume 208, 1-3 (2003)
    • A genetic basis for human gammadelta T cell reactivity towards microbial pathogens
      Eberl M, Jomaa H, , Berlin, Germany (September 2003) Immunobiology, Volume 208, 1-3 (2003)
    • Human Vg9/Vd2 effector memory T cells express killer cell lectin-like receptor G1
      Eberl M, Pircher H, , Berlin, Germany (September 2003) Immunobiology, Volume 208, 1-3 (2003)
  • 2002
    • Differentiation of human gammadelta T cells towards distinct memory phenotypes
      Eberl M, Engel R, Jomaa H, , Harrogate, U.K. (December 2002) Immunology, Volume 107, S1 (December 2002)
    • Differentiation of human gammadelta T cells towards distinct memory phenotypes
      Eberl M, Engel R, Beck E, Jomaa H, , Marburg, Germany (September 2002) Immunobiology, Volume 206, 1-3 (September 2002)
  • 2001
    • Characterisation of a potent gammadelta T cell activator accumulating after deletion of the lytB gene in E. coli
      Eberl M, Altincicek B, Reichenberg A, Bahr U, Gschwind R, Kollas AK, Böhm M, Hintz M, Jomaa H, , Harrogate, U.K. (December 2001) Immunology, Volume 104, S1 (December 2001)
  • 1998
    • A novel approach to identify vaccine candidates against schistosomiasis
      Eberl M, Mountford AP, Jankovic D, Beck E, , Harrogate, U.K. (December 1998) (1998)
  • 1997
    • A novel method for identifying T cell antigens using a recombinant protein library
      Eberl M, Beck E, , Würzburg, Germany (September 1997) Immunobiology, Volume 197, 2-4 (September 1997)